Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Spinal cord injury (SCI) is a central nervous system- (CNS-) related disorder for which there is yet no successful treatment. Within the past several years, cell-based therapies have been explored for SCI repair, including the use of pluripotent human stem cells, and a number of adult-derived stem and mature cells such as mesenchymal stem cells, olfactory ensheathing cells, and Schwann cells. Although promising, cell transplantation is often overturned by the poor cell survival in the treatment of spinal cord injuries. Alternatively, the therapeutic role of different cells has been used in tissue engineering approaches by engrafting cells with biomaterials. The latter have the advantages of physically mimicking the CNS tissue, while promoting a more permissive environment for cell survival, growth, and differentiation. The roles of both cell- and biomaterial-based therapies as single therapeutic approaches for SCI repair will be discussed in this review. Moreover, as the multifactorial inhibitory environment of a SCI suggests that combinatorial approaches would be more effective, the importance of using biomaterials as cell carriers will be herein highlighted, as well as the recent advances and achievements of these promising tools for neural tissue regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 1×
“neering applications [195].”
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727
Alginate hydrogels as synthetic extracellular matrix materials
Rowley, J. A., Madlambayan, G., & Mooney, D. J. (1999) · Biomaterials · doi:10.1016/s0142-9612(98)00107-0 · Cited by 2,342
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004) · Circulation · doi:10.1161/01.cir.0000121425.42966.f1 · Cited by 2,269 · cited 1×
“As other synthetic hydrogels, PHEMA/PHEMA-MMA polymers have the disadvantage of being nonbiodegradable [107, 122].”
BackgroundAdult mesenchymal stem cells for tissue engineering versus regenerative medicine
Caplan, A. I. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21200 · Cited by 1,956 · cited 1×
“Indeed, it is more likely that the MSCs potential is associated with their trophic activity [28, 29, 55, 62, 63].”
BackgroundFibrinogen and fibrin structure and functions
MOSESSON, M. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01365.x · Cited by 1,695
Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture
Ying, Q.-L., Stavridis, M., Griffiths, D., Li, M., & Smith, A. (2003) · Nature Biotechnology · doi:10.1038/nbt780 · Cited by 1,504 · cited 1×
“Upon evaluation of the severity of the damage, the lesion is broadly characterized as complete or incomplete [8, 9], with distinct clinical implications to the patients (e.g., paralysis, sensory loss, intractable pain, pressure sores, and urinary/other infections) [5, 8].”
BackgroundKobayashi, Y., Okada, Y., Itakura, G., Iwai, H., Nishimura, S., Yasuda, A., Nori, S., Hikishima, K., Konomi, T., Fujiyoshi, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052787 · Cited by 315
Aligned neurite outgrowth and directed cell migration in self-assembled monodomain gels
Berns, E. J., Sur, S., Pan, L., Goldberger, J. E., Suresh, S., Zhang, S., Kessler, J. A., & Stupp, S. I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.077 · Cited by 208
Fibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor
Schachtrup, C., Lu, P., Jones, L. L., Lee, J. K., Lu, J., Sachs, B. D., Zheng, B., & Akassoglou, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704045104 · Cited by 117
Cited by
Fan, L., Liu, C., Chen, X., Zou, Y., Zhou, Z., Lin, C., Tan, G., Zhou, L., Ning, C., & Wang, Q. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05293 · Cited by 275
Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair
Tukmachev, D., Forostyak, S., Koci, Z., Zaviskova, K., Vackova, I., Vyborny, K., Sandvig, I., Sandvig, A., Medberry, C. J., Badylak, S. F., et al. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0422 · Cited by 160
“In addition to these approaches, tissue engineered scaffolds play an important role in providing supportive substrates that contribute to replacing lost tissue and re-establishing damaged connections after SCI (4-7).”
Metadata
- Authors
- Assunção-Silva, R. C., Gomes, E. D., Sousa, N., Silva, N. A., & Salgado, A. J.
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-24
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- OpenAlex
- W1850848829
- Cited by
- 186
- References
- 10
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.